Your healthcare team can provide guidance on dietary modifications, physical activity programmes, and psychological support that complement pharmacological treatment
Healthcare providers often evaluate possible interactions, patient health status, and monitoring needs before recommending this combination
Effects of L-carnitine on exercise tolerance in chronic stable angina: a multicenter, double-blind, randomized, placebo-controlled, crossover study
If GLP-1 therapy is initiated , a structured monitoring plan should include: Regular assessment of weight, BMI and nutritional status Monitoring of hydration and renal function, particularly if experiencing significant gastrointestinal symptoms For diabetes patients, appropriate retinopathy surveillance if glycaemic control improves rapidly (especially with semaglutide) [5] [11] Regular review of Crohn's disease activity using clinical and biochemical markers Remember that you are an active participant in your healthcare decisions, and your concerns and experiences should guide the treatment plan